切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2025, Vol. 11 ›› Issue (04) : 380 -386. doi: 10.3877/cma.j.issn.2096-1537.2025.04.008

综述

连续葡萄糖监测在重症患者中的应用进展
高明, 许媛, 周华()   
  1. 102218 北京,清华大学北京清华长庚医院 重症医学科
  • 收稿日期:2025-07-16 出版日期:2025-11-28
  • 通信作者: 周华
  • 基金资助:
    北京清华长庚医院研究基金项目(12025C01001)

The performance of continuous glucose monitoring in critically ill patients

Ming Gao, Yuan Xu, Hua Zhou()   

  1. Department of Critical Care Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing 102218, China
  • Received:2025-07-16 Published:2025-11-28
  • Corresponding author: Hua Zhou
引用本文:

高明, 许媛, 周华. 连续葡萄糖监测在重症患者中的应用进展[J/OL]. 中华重症医学电子杂志, 2025, 11(04): 380-386.

Ming Gao, Yuan Xu, Hua Zhou. The performance of continuous glucose monitoring in critically ill patients[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2025, 11(04): 380-386.

重症患者的血糖监测是血糖精益化管理中的重要一环。连续葡萄糖监测(CGM)可改善血糖达标时间、减少低血糖事件,在糖尿病患者中已广泛应用。其连续密集的葡萄糖监测数据、多种可分析的血糖动态指标、创伤小、降低医护人员工作量等优点,越来越受到ICU从业人员的关注。但由于重症患者的病情危重、病理生理变化迅速,CGM是否适用于重症患者尚存争议。本文就近年来针对重症患者CGM的准确性、是否可改善血糖控制质量以及临床预后等方面的进展做出阐述。

Blood glucose monitoring and management in critically ill patients constitutes an important part of intensive care. Continuous glucose monitoring (CGM) can improve the time in the target blood glucose range and reduce hypoglycemic events, and it has been widely used in patients with diabetes. Its advantages, including continuous glucose data collection, multiple glucose dynamic indicators, minimal invasiveness and reduced workload for medical staff, have drawn increasing attention from ICU clinicians. However, the clinical applicability of CGM in ICU patients remains controversial due to the critical conditions and rapid pathophysiological changes. This article elaborates on the recent progress regarding the accuracy of CGM in critically ill patients, as well as whether it can improve the quality of blood glucose control and clinical prognosis.

1
Lönnroth P, Jansson PA, Smith U. A microdialysis method allowing characterization of intercellular water space in humans [J]. Am J Physiol, 1987, 253(2 Pt 1): E228-231.
2
Mihai DA, Stefan DS, Stegaru D, et al. Continuous glucose monitoring devices: a brief presentation (Review) [J]. Exp Ther Med, 2022, 23(2): 174-179.
3
中华医学会糖尿病学分会. 中国血糖监测临床应用指南 (2021年版) [J]. 中华糖尿病杂志, 2021, 13(10): 936-948.
4
He HM, Zheng SW, Xie YY, et al. Simultaneous assessment of stress hyperglycemia ratio and glycemic variability to predict mortality in patients with coronary artery disease: a retrospective cohort study from the MIMIC-Ⅳ database [J]. Cardiovasc Diabetol, 2024, 23(1): 61-74.
5
Thongsuk Y, Hwang NC. Perioperative glycemic management in cardiac surgery: a narrative review [J]. J Cardiothorac Vasc Anesth, 2024, 38(1): 248-267.
6
Piper HG, Alexander JL, Shukla A, et al. Real-time continuous glucose monitoring in pediatric patients during and after cardiac surgery [J]. Pediatrics, 2006, 118(3): 1176-1184.
7
Siegelaar SE, Barwari T, Hermanides J, et al. Microcirculation and its relation to continuous subcutaneous glucose sensor accuracy in cardiac surgery patients in the intensive care unit [J]. J Thorac Cardiovasc Surg, 2013, 146(5): 1283-1289.
8
Kalmovich B, Bar-Dayan Y, Boaz M, et al. Continuous glucose monitoring in patients undergoing cardiac surgery [J]. Diabetes Technol Ther, 2012, 14(3): 232-238.
9
Insler SR, Wakefield B, Debs A, et al. Continuous glucose monitoring using the Dexcom G6 in cardiac surgery during the postoperative period [J]. Endocr Pract, 2024, 30(7): 610-615.
10
Herzig D, Vettoretti M, Guensch DP, et al. Performance of the Dexcom G6 continuous glucose monitoring system during cardiac surgery using hypothermic extracorporeal circulation [J]. Diabetes Care, 2023, 46(4): 864-867.
11
Perez-Guzman MC, Duggan E, Gibanica S, et al. Continuous glucose monitoring in the operating room and cardiac intensive care unit [J]. Diabetes Care, 2021, 44(3): e50-e52.
12
Gu J, Zhao Z, Li H, et al. Accuracy of Freestyle Libre continuous glucose monitoring system in critically ill patients after cardiac surgery [J]. J Cardiothorac Surg, 2025, 20(1): 75-80.
13
Sweeney AT, Pena S, Sandeep J, et al. Use of a Continuous glucose monitoring system in high-risk hospitalized noncritically ill patients with diabetes after cardiac surgery and during their transition of care from the intensive care unit during COVID-19: a pilot study [J]. Endocr Pract, 2022, 28(6): 615-621.
14
Fortmann AL, Spierling Bagsic SR, Talavera L, et al. Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting [J]. Diabetes Care, 2020, 43(11): 2873-2877.
15
Lin J, Chen Y, Xu M, et al. Association and predictive ability between significant perioperative cardiovascular adverse events and stress glucose rise in patients undergoing non-cardiac surgery [J]. Cardiovasc Diabetol, 2024, 23(1): 445-458.
16
Choi YJ, Jeon SM, Yu S, et al. Accuracy and feasibility of continuous glucose monitoring system in pancreatectomy patients [J]. Langenbecks Arch Surg, 2025, 410(1): 32-39.
17
Leelarathna L, English SW, Thabit H, et al. Accuracy of subcutaneous continuous glucose monitoring in critically ill adults: improved sensor performance with enhanced calibrations [J]. Diabetes Technol Ther, 2014, 16(2): 97-101.
18
Bann SA, Hercus JC, Atkins P, et al. Accuracy of a continuous glucose monitor in the intensive care unit: a proposed accuracy standard and calibration protocol for inpatient use [J]. Diabetes Technol Ther, 2024, 26(11): 797-805.
19
Voglová Hagerf B, Protus M, Nemetova L, et al. Accuracy and feasibility of real-time continuous glucose monitoring in critically ill patients after abdominal surgery and solid organ transplantation [J]. Diabetes Care, 2024, 47(6): 956-963.
20
Lim HA, Kim M, Kim NJ, et al. The performance of continuous glucose monitoring during the intraoperative period: a scoping review [J]. J Clin Med, 2024, 13(20): 6169-6192.
21
van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients [J]. N Engl J Med, 2001, 345(19): 1359-1367.
22
Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients [J]. N Engl J Med, 2009, 360(13): 1283-1297.
23
Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis [J]. N Engl J Med, 2008, 358(2): 125-139.
24
Holzinger U, Warszawska J, Kitzberger R, et al. Impact of shock requiring norepinephrine on the accuracy and reliability of subcutaneous continuous glucose monitoring [J]. Intensive Care Med, 2009, 35(8): 1383-1389.
25
Ballesteros D, Martínez Ó, Blancas Gómez-Casero R, et al. Continuous tissue glucose monitoring correlates with measurement of intermittent capillary glucose in patients with distributive shock [J]. Medicina Intensiva, 2015, 39(7): 405-411.
26
Yue XY, Zheng Y, Cai YH, et al. Real-time continuous glucose monitoring shows high accuracy within 6 hours after sensor calibration: a prospective study [J]. PLoS One, 2013, 8(3): e60070.
27
Corstjens AM, Ligtenberg JJ, van der Horst IC, et al. Accuracy and feasibility of point-of-care and continuous blood glucose analysis in critically ill ICU patients [J]. Crit Care, 2006, 10(5): R135.
28
Brunner R, Kitzberger R, Miehsler W, et al. Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients [J]. Crit Care Med, 2011, 39(4): 659-664.
29
Naraba H, Goto T, Tokuda M, et al. Accuracy and stability of a subcutaneous flash glucose monitoring system in critically ill patients [J]. J Diabetes Sci Technol, 2022, 16(5): 1128-1135.
30
Van Hooijdonk RT, Leopold JH, Winters T, et al. Point accuracy and reliability of an interstitial continuous glucose-monitoring device in critically ill patients: a prospective study [J]. Crit Care, 2015, 19(1): 34-43.
31
Wollersheim T, Engelhardt LJ, Pachulla J, et al. Accuracy, reliability, feasibility and nurse acceptance of a subcutaneous continuous glucose management system in critically ill patients: a prospective clinical trial [J]. Ann Intensive Care, 2016, 6(1): 70-83.
32
Rijkenberg S, van Steen SC, DeVries JH, et al. Accuracy and reliability of a subcutaneous continuous glucose monitoring device in critically ill patients [J]. J Clin Monit Comput, 2018, 32(5): 953-964.
33
Mårtensson J, Cutuli S, Yanase F, et al. Glycemic control and blood gas sampling frequency during continuous glucose monitoring in the intensive care unit: a before-and-after study [J]. Acta Anaesthesiol Scand, 2023, 67(1): 86-93.
34
Nielsen CG, Grigonyte-Daraskeviciene M, Olsen MT, et al. Accuracy of continuous glucose monitoring systems in intensive care unit patients: a scoping review [J]. Intensive Care Med, 2024, 50(12): 2005-2018.
35
Teo E, Hassan N, Tam W, et al. Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis [J]. Diabetologia, 2022, 65(4): 604-619.
36
Singh LG, Satyarengga M, Marcano I, et al. Reducing inpatient hypoglycemia in the general wards using real-time continuous glucose monitoring: the glucose telemetry system, a randomized clinical trial [J]. Diabetes Care, 2020, 43(11): 2736-2743.
37
Li Y, Cai L, Lu Q, et al. Time-divided hypoglycemia management derived by continuous glucose monitoring may reduce microvascular diseases in type 2 diabetes patients [J]. Endocrine, 2025, 89(1): 99-110.
38
Holzinger U, Warszawska J, Kitzberger R, et al. Real-time continuous glucose monitoring in critically ill patients: a prospective randomized trial [J]. Diabetes Care, 2010, 33(3): 467-472.
39
Lu M, Zuo Y, Guo J, et al. Continuous glucose monitoring system can improve the quality of glucose control and glucose variability compared with point-of-care measurement in critically ill patients: a randomized controlled trial [J]. Medicine (Baltimore), 2018, 97(36): e12138.
40
Yao Y, Zhao YH, Zheng WH, et al. Subcutaneous continuous glucose monitoring in critically ill patients during insulin therapy: a meta-analysis [J]. Am J Transl Res, 2022, 14(7): 4757-4767.
41
Chu C, Li J, Yang X, et al. Continuous glucose monitoring versus conventional glucose monitoring in the ICU: a randomized controlled trial [J]. J Crit Care, 2024, 84: 154894.
42
Shang J, Yuan Z, Zhang Z, et al. Effectiveness of continuous glucose monitoring on short-term, in-hospital mortality among frail and critically ill patients with COVID-19: randomized controlled trial [J]. J Med Internet Res, 2025, 27: e67012.
43
Franck AJ, Hendrickson AL, Telford ED, et al. Continuous glucose monitoring for hyperglycemia in critically ill patients: a randomized controlled trial [J]. Chest, 2025, 168(2): 326-335.
44
Huang X, Liang B, Huang S, et al. Integrated electronic/fluidic microneedle system for glucose sensing and insulin delivery [J]. Theranostics, 2024, 14(4): 1662-1682.
45
Park E, Kim M. Clinical Use of continuous glucose monitoring in critically ill pediatric patients with diabetic ketoacidosis [J]. Diabetes Technol Ther, 2023, 25(8): 529-537.
46
Garg SK, Kipnes M, Castorino K, et al. Accuracy and safety of Dexcom G7 continuous glucose monitoring in adults with diabetes [J]. Diabetes Technol Ther, 2022, 24(6): 373-380.
47
Song IK, Lee JH, Kang JE, et al. Continuous glucose monitoring system in the operating room and intensive care unit: any difference according to measurement sites? [J]. J Clin Monit Comput, 2017, 31(1): 187-194.
48
中华医学会糖尿病学分会. 中国动态血糖监测临床应用指南 (2012年版) [J]. 中华糖尿病杂志, 2012, 4(10): 582-590.
49
Cengiz E, Tamborlane WV. A tale of two compartments: interstitial versus blood glucose monitoring [J]. Diabetes Technol Ther, 2009, 11 Suppl 1(Suppl 1): S11-16.
50
Phongmekhin T, Wang R. Continuous glucose monitor accuracy during extracorporeal membrane oxygenation [J]. Crit Care Resusc, 2024, 26(1): 58-59.
51
中华医学会重症医学分会. 中国成人ICU患者营养评估与监测临床实践指南 [J/OL]. 中华重症医学电子杂志, 2023, 9(4): 321-348.
52
Hanaire H, Ozdemir Saltik AZ, Pollock RF, et al. Cost-utility analysis of the MiniMed™ 780G advanced hybrid closed-loop system versus intermittently scanned continuous glucose monitoring with multiple daily insulin injections in people with type 1 diabetes in France [J]. Diabetes Technol Ther, 2025, 27(10): 768-777.
[1] 浙江省医疗数据产业研究会心脏重症分会, 中国医师协会心脏重症专业委员会. 心脏重症监护病房建设中国专家共识[J/OL]. 中华危重症医学杂志(电子版), 2025, 18(06): 476-483.
[2] 李东晖. 重症烧伤患者多重耐药菌感染风险的机器学习预测模型构建及验证[J/OL]. 中华实验和临床感染病杂志(电子版), 2025, 19(06): 368-377.
[3] 杨德建, 晏东, 戴忠红, 黎宏, 杨鹏, 钟常文. 平均血小板体积/血小板计数、乳酸/白蛋白比值对119例重症肺炎预后预测的价值研究[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(01): 132-138.
[4] 刘宝德, 郑娉娉, 肖宇翔, 沈凌, 王柳盛, 张维. 肺泡灌洗液中炎症因子对重症肺炎患者痰栓风险的预测分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 917-922.
[5] 马彬, 王启超, 王圣元, 赵虎林, 沈玥. 俯卧位通气管理在59例重症肺炎患者中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(06): 1012-1014.
[6] 刘虹, 李国蓉, 战祥哲, 高海燕, 刘洪千, 赵永辉. 高频胸壁振荡排痰与传统气道廓清术在治疗重症肺炎中的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(05): 802-806.
[7] 唐杉杉, 吴红梅, 王爽, 周静, 王露梦, 彭茜. 重症肺炎合并急性呼吸窘迫综合征继发多器官衰竭救治成功一例[J/OL]. 中华肺部疾病杂志(电子版), 2025, 18(05): 844-846.
[8] 崔琳琳, 薛来恩, 付云烽, 王君竹, 郑和平, 路君, 徐永君. 大鼠羊膜间充质干细胞对STZ损伤的大鼠胰岛修复作用研究[J/OL]. 中华细胞与干细胞杂志(电子版), 2025, 15(06): 321-328.
[9] 陆含笑, 吴波, 陈海艳, 周惠敏, 杨军. 肠道清洁治疗重症急性胰腺炎研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(06): 834-843.
[10] 董艳, 郭继武, 毛杰. 儿童重症急性胰腺炎一例诊治分析并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(06): 956-961.
[11] 倪琛, 邬步云, 毛慧娟. 2025年法国重症监护室中急性肾损伤的肾脏替代治疗指南解读[J/OL]. 中华肾病研究电子杂志, 2026, 15(01): 1-7.
[12] 张静, 王帅鹏, 何竟. 重症康复疑难病例讨论+PBL法对康复团队临床能力培养的效果评价及现状分析[J/OL]. 中华脑科疾病与康复杂志(电子版), 2026, 16(01): 46-51.
[13] 马博, 李涛, 董扬帆, 商少华, 马华, 王俊, 纪文静. 减重代谢手术改善2型糖尿病肥胖患者胃肠肽及血糖的前瞻性研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(01): 53-60.
[14] 高兴梅, 周洁容, 杨溢, 张孟祥, 张仲谋, 李斌. 重症肺炎患者血磷水平轨迹与短期预后之间的关系[J/OL]. 中华临床医师杂志(电子版), 2025, 19(07): 479-485.
[15] 魏伟. 老年危重症患者并发急性肾损伤的危险因素的临床研究[J/OL]. 中华卫生应急电子杂志, 2025, 11(06): 365-369.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?